Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target

Neuroinflammation regulated by microglia is one of the important factors involved in the pathogenesis of Alzheimer’s disease (AD). Activated microglia exhibited phenotypes termed as M1 and M2 phenotypes separately. M1 microglia contribute to the development of inflammation via upregulating pro-infla...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Qinqin Wang, Hongmei Yao, Wenyan Liu, Bailiu Ya, Hongju Cheng, Zhenkai Xing, Yili Wu
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/8d696d9970a149f282ea1ddc4471fcb7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8d696d9970a149f282ea1ddc4471fcb7
record_format dspace
spelling oai:doaj.org-article:8d696d9970a149f282ea1ddc4471fcb72021-11-08T04:57:56ZMicroglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target1663-436510.3389/fnagi.2021.772717https://doaj.org/article/8d696d9970a149f282ea1ddc4471fcb72021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fnagi.2021.772717/fullhttps://doaj.org/toc/1663-4365Neuroinflammation regulated by microglia is one of the important factors involved in the pathogenesis of Alzheimer’s disease (AD). Activated microglia exhibited phenotypes termed as M1 and M2 phenotypes separately. M1 microglia contribute to the development of inflammation via upregulating pro-inflammatory cytokines, while M2 microglia exert anti-inflammation effects through enhancing the expression of anti-inflammation factors. Moreover, M1 and M2 microglia could be mutually transformed under various conditions. Both M1 and M2 microglia are implicated in AD. Amyloid-β (Aβ) and hyperphosphorylated tau are two major components of AD pathological hallmarks, neuritic plaques, and neurofibrillary tangles. Both Aβ and hyperphosphorylated tau were involved in microglial activation and subsequent inflammation, which further contribute to neuronal and synaptic loss in AD. In this review, we summarized the roles of M1 and M2 microglia in AD and underlying mechanisms, which will provide an insight into the role of microglia in the pathogenesis of AD and highlight the therapeutic potential of modulating microglia.Qinqin WangHongmei YaoWenyan LiuBailiu YaHongju ChengZhenkai XingYili WuYili WuYili WuFrontiers Media S.A.articleneuroinflammationmicroglia activationM1 microgliaM2 microgliaAlzheimer’s diseaseNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENFrontiers in Aging Neuroscience, Vol 13 (2021)
institution DOAJ
collection DOAJ
language EN
topic neuroinflammation
microglia activation
M1 microglia
M2 microglia
Alzheimer’s disease
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle neuroinflammation
microglia activation
M1 microglia
M2 microglia
Alzheimer’s disease
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Qinqin Wang
Hongmei Yao
Wenyan Liu
Bailiu Ya
Hongju Cheng
Zhenkai Xing
Yili Wu
Yili Wu
Yili Wu
Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target
description Neuroinflammation regulated by microglia is one of the important factors involved in the pathogenesis of Alzheimer’s disease (AD). Activated microglia exhibited phenotypes termed as M1 and M2 phenotypes separately. M1 microglia contribute to the development of inflammation via upregulating pro-inflammatory cytokines, while M2 microglia exert anti-inflammation effects through enhancing the expression of anti-inflammation factors. Moreover, M1 and M2 microglia could be mutually transformed under various conditions. Both M1 and M2 microglia are implicated in AD. Amyloid-β (Aβ) and hyperphosphorylated tau are two major components of AD pathological hallmarks, neuritic plaques, and neurofibrillary tangles. Both Aβ and hyperphosphorylated tau were involved in microglial activation and subsequent inflammation, which further contribute to neuronal and synaptic loss in AD. In this review, we summarized the roles of M1 and M2 microglia in AD and underlying mechanisms, which will provide an insight into the role of microglia in the pathogenesis of AD and highlight the therapeutic potential of modulating microglia.
format article
author Qinqin Wang
Hongmei Yao
Wenyan Liu
Bailiu Ya
Hongju Cheng
Zhenkai Xing
Yili Wu
Yili Wu
Yili Wu
author_facet Qinqin Wang
Hongmei Yao
Wenyan Liu
Bailiu Ya
Hongju Cheng
Zhenkai Xing
Yili Wu
Yili Wu
Yili Wu
author_sort Qinqin Wang
title Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target
title_short Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target
title_full Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target
title_fullStr Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target
title_full_unstemmed Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target
title_sort microglia polarization in alzheimer’s disease: mechanisms and a potential therapeutic target
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/8d696d9970a149f282ea1ddc4471fcb7
work_keys_str_mv AT qinqinwang microgliapolarizationinalzheimersdiseasemechanismsandapotentialtherapeutictarget
AT hongmeiyao microgliapolarizationinalzheimersdiseasemechanismsandapotentialtherapeutictarget
AT wenyanliu microgliapolarizationinalzheimersdiseasemechanismsandapotentialtherapeutictarget
AT bailiuya microgliapolarizationinalzheimersdiseasemechanismsandapotentialtherapeutictarget
AT hongjucheng microgliapolarizationinalzheimersdiseasemechanismsandapotentialtherapeutictarget
AT zhenkaixing microgliapolarizationinalzheimersdiseasemechanismsandapotentialtherapeutictarget
AT yiliwu microgliapolarizationinalzheimersdiseasemechanismsandapotentialtherapeutictarget
AT yiliwu microgliapolarizationinalzheimersdiseasemechanismsandapotentialtherapeutictarget
AT yiliwu microgliapolarizationinalzheimersdiseasemechanismsandapotentialtherapeutictarget
_version_ 1718443020086411264